CreateAIGen is a versatile AI-powered content creation platform designed to generate high-quality text, stunning images, and efficient code. It serves as an all-in-one solution for marketers, developers, and content creators, streamlining workflows and boosting productivity with its intuitive interface and advanced AI models.
SinCode was an all-in-one AI content creation platform offering a suite of tools for writing, image generation, and coding. The project has been discontinued, and its domain now directs users to agent.ai, a platform with various AI agent tools.
Product overview
CreateAIGen Product overview
CreateAIGen is a versatile AI-powered content creation platform designed to generate high-quality text, stunning images, and efficient code. It serves as an all-in-one solution for marketers, developers, and content creators, streamlining workflows and boosting productivity with its intuitive interface and advanced AI models.
SinCode Product overview
SinCode was an all-in-one AI content creation platform offering a suite of tools for writing, image generation, and coding. The project has been discontinued, and its domain now directs users to agent.ai, a platform with various AI agent tools.
Detailed feature comparison
| Feature | CreateAIGen | SinCode |
|---|---|---|
| Primary category | Image Generation | Image Generation |
| Added | 2025-08-01 | 2025-08-15 |
| Pricing | Freemium | Not verified |
| Official website | createaigen.com | agent.ai |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 3.5K | 341.3K |
| Monthly growth | Not verified | 1% |
| Favorites | 113 | 103 |
| Details | View details | View details |
CreateAIGen vs SinCode monthly traffic
Compare CreateAIGen and SinCode by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the CreateAIGen vs SinCode monthly traffic comparison, CreateAIGen currently shows 3.5K visits and SinCode shows 341.3K; SinCode has about 97.8 times the visible traffic of CreateAIGen, an absolute difference of about 337.8K visits. This reflects visible reach, not feature quality or paid users.
Only SinCode has complete third-party traffic details; CreateAIGen uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
SinCode is registered at the agent.ai/sincode subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
CreateAIGen monthly traffic:
Latest traffic
SinCode monthly traffic:
Latest traffic
Monthly traffic trend
- 2026/1: 427.4K Monthly visits
- 2026/2: 322.5K Monthly visits
- 2026/3: 355.7K Monthly visits
- 2026/4: 337.8K Monthly visits
- 2026/5: 341.3K Monthly visits
Top regions
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 40.16% | 137.1K |
| 🇮🇳India | 36.14% | 123.3K |
| 🇻🇳Vietnam | 9.12% | 31.1K |
| 🇨🇦Canada | 7.85% | 26.8K |
| 🇺🇦Ukraine | 6.73% | 23K |
Traffic sources
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 83.91% | 286.4K |
| Referral | 14.61% | 49.9K |
| 1.48% | 5.1K |
Search keywords
Usage comparison
Compare the core capabilities of CreateAIGen and SinCode
CreateAIGen Core features
SinCode Core features
Use cases
CreateAIGen Use cases
SinCode Use cases
CreateAIGen vs SinCode:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth CreateAIGen vs SinCode comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. CreateAIGen is primarily listed under “Image Generation”, while SinCode is primarily listed under “Image Generation”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Pricing (CreateAIGen: Freemium; SinCode: Not disclosed); Monthly visits (CreateAIGen: 3.5K; SinCode: 341.3K); Favorites (CreateAIGen: 113; SinCode: 103); Website (CreateAIGen: createaigen.com; SinCode: agent.ai); Added (CreateAIGen: 2025-08-01; SinCode: 2025-08-15). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the CreateAIGen vs SinCode monthly traffic comparison, CreateAIGen currently shows 3.5K visits and SinCode shows 341.3K; SinCode has about 97.8 times the visible traffic of CreateAIGen, an absolute difference of about 337.8K visits. This reflects visible reach, not feature quality or paid users.
Only SinCode has complete third-party traffic details; CreateAIGen uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
SinCode is registered at the agent.ai/sincode subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
SinCode is registered under a agent.ai subpath, so its large visible total may include the host platform. The current data does not justify choosing SinCode for traffic alone; shortlist by unique taxonomy and use case, then validate with the same tasks.
Product positioning, use cases, and roles
CreateAIGen and SinCode currently overlap in shared categories: Image Generation, Code Assistant, Content Creation, and Writing; shared tags: code assistant, image generator, and marketing. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
CreateAIGen's unique categories/tags are AI content generator, all-in-one ai, developer tools, text generator, and writing assistant; SinCode's are ai writer, all-in-one, content creation, copywriting, discontinued, and productivity. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
CreateAIGen has no verified rating, 0 comments, 113 favorites, and 131 likes;SinCode has no verified rating, 0 comments, 103 favorites, and 108 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate CreateAIGen first
Put CreateAIGen on the priority trial list when the task aligns with “Image Generation” and especially AI content generator, all-in-one ai, developer tools, text generator, and writing assistant. This follows recorded positioning and does not imply unlisted capabilities are absent.
CreateAIGen also currently records: pricing is freemium, product type is website, 3.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate SinCode first
Put SinCode on the priority trial list when the task aligns with “Image Generation” and especially ai writer, all-in-one, content creation, copywriting, discontinued, and productivity. This follows recorded positioning and does not imply unlisted capabilities are absent.
SinCode also currently records: pricing is not verified, product type is website, 341.3K monthly visits shown for the registered host (subpage scope unknown), no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in CreateAIGen and SinCode, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




